Northern Trust Corp increased its holdings in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 12.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 535,334 shares of the company's stock after acquiring an additional 60,111 shares during the quarter. Northern Trust Corp owned approximately 0.31% of BrightSpring Health Services worth $9,117,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. grew its position in BrightSpring Health Services by 275.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 163,618 shares of the company's stock worth $2,402,000 after purchasing an additional 120,005 shares during the last quarter. Legato Capital Management LLC boosted its stake in shares of BrightSpring Health Services by 40.0% during the fourth quarter. Legato Capital Management LLC now owns 66,910 shares of the company's stock worth $1,139,000 after buying an additional 19,120 shares during the period. SG Americas Securities LLC grew its holdings in shares of BrightSpring Health Services by 50.9% during the fourth quarter. SG Americas Securities LLC now owns 37,000 shares of the company's stock worth $630,000 after buying an additional 12,486 shares during the last quarter. Barclays PLC increased its position in BrightSpring Health Services by 22.2% in the 3rd quarter. Barclays PLC now owns 393,725 shares of the company's stock valued at $5,780,000 after acquiring an additional 71,633 shares during the period. Finally, Raymond James Financial Inc. acquired a new position in BrightSpring Health Services in the 4th quarter valued at about $18,257,000.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the company. UBS Group increased their price objective on BrightSpring Health Services from $22.00 to $30.00 and gave the stock a "buy" rating in a research report on Wednesday, January 29th. Wells Fargo & Company increased their price target on BrightSpring Health Services from $25.00 to $27.00 and gave the stock an "overweight" rating in a report on Tuesday, May 13th. Mizuho set a $26.00 price objective on shares of BrightSpring Health Services in a research report on Monday, May 5th. Finally, Morgan Stanley upped their price objective on shares of BrightSpring Health Services from $20.00 to $25.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, BrightSpring Health Services has an average rating of "Moderate Buy" and a consensus price target of $23.56.
Read Our Latest Stock Report on BTSG
BrightSpring Health Services Price Performance
Shares of BrightSpring Health Services stock traded down $0.82 during trading on Thursday, reaching $22.92. The company's stock had a trading volume of 1,791,373 shares, compared to its average volume of 1,422,281. The business has a 50 day moving average price of $18.98 and a 200-day moving average price of $19.14. BrightSpring Health Services, Inc. has a 12-month low of $10.15 and a 12-month high of $24.82. The company has a market capitalization of $3.99 billion, a P/E ratio of -88.15 and a beta of 2.06. The company has a quick ratio of 0.97, a current ratio of 1.35 and a debt-to-equity ratio of 1.63.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last released its earnings results on Friday, May 2nd. The company reported $0.19 EPS for the quarter, beating analysts' consensus estimates of $0.09 by $0.10. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The company had revenue of $2.88 billion during the quarter, compared to the consensus estimate of $2.74 billion. During the same quarter last year, the company earned $0.12 earnings per share. BrightSpring Health Services's quarterly revenue was up 25.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that BrightSpring Health Services, Inc. will post 0.59 EPS for the current year.
About BrightSpring Health Services
(
Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
See Also

Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.